Therapy for Progressive and/or Refractory Hematologic Malignancies

NCT02223312 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision to discontinue study.

Conditions

Cancer
Hematologic Malignancies

Interventions

BIOLOGICAL: TAPA-pulsed DC vaccine

Sponsor

Kiromic BioPharma Inc.